Efficacy of primary silicone oil tamponade for the treatment of retinal detachment caused by macular hole in high myopia.
OBJECTIVE
To determine the effect of pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling and primary silicone oil tamponade without any postoperative position restrictions for retinal detachment (RD) caused by macular hole in high myopia.


METHODS
Retrospective, interventional case series.


METHODS
Twenty-four eyes of 24 patients with RD caused by macular hole in high myopia (axial length more than 27.0 mm) were treated by PPV with ILM peeling and primary silicone oil tamponade. No position restrictions were issued to patients postoperatively.


RESULTS
The retina reattached in 22 eyes (92%) following the initial surgery. The final retinal reattachment rate was 100% after a second surgery of macular buckling for the 2 eyes with initial failure. For eyes with initial successful reattachment, the mean best-corrected visual acuity (BCVA) was significantly improved from 1.8 ± 0.5 logMAR units before surgery to 1.2 ± 0.4 (P < .001, paired t test). No clinical factors were significantly associated with improvement of BCVA or macular hole closure using multivariate analysis.


CONCLUSIONS
For the treatment of RD caused by macular hole, PPV with ILM peeling and primary silicone oil tamponade showed a high retinal reattachment rate without any postoperative position restrictions. It also improved postoperative BCVA significantly. This may be a preferable method for the treatment of RD caused by macular hole in high myopia.
Department of Ophthalmology and Visual Science, Kanazawa University Graduate School of Medical Science, Japan. eyenishi@med.kanazawa-u.ac.jp
Akira
A
Nishimura
Masayo
M
Kimura
Yoshiaki
Y
Saito
Kazuhisa
K
Sugiyama
D000368:Aged; D004396:Coloring Agents; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007208:Indocyanine Green; D008297:Male; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D012163:Retinal Detachment / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D012167:Retinal Perforations / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D012189:Retrospective Studies; D012591:Scleral Buckling; D012827:Silicone Oils / Q000008:administration & dosage*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy
D004396:Coloring Agents; D012827:Silicone Oils; D007208:Indocyanine Green